Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19.

Ravindra GaneshColin PawlowskiJohn C O'HoroLori L ArndtRichard ArndtSarah J BellDennis M BierleMolly Destro BorgenSara N HansonAlexander HeyligerJennifer J LarsenPatrick J LenehanRobert OrensteinArjun PuranikLeigh L SpeicherSidna M Tulledge-ScheitelA J VenkatakrishnanCaroline G WilkerAndrew D BadleyRaymund R Razonable

Published in: medRxiv : the preprint server for health sciences (2021)

Mayo Clinic.

Keyphrases

intensive care unit
coronavirus disease
sars cov
emergency department
cardiovascular events
primary care
high dose
mechanical ventilation
risk factors
cardiovascular disease
respiratory syndrome coronavirus
low dose
type diabetes